NAV

bis(4-nitrophenyl) hydrogen phosphate

Identification

Generic Name
bis(4-nitrophenyl) hydrogen phosphate
DrugBank Accession Number
DB07418
Background

Not Available

Type
Small Molecule
Groups
Experimental
Structure
3D
Similar Structures
Weight
Average: 340.1822
Monoisotopic: 340.009651786
Chemical Formula
C12H9N2O8P
Synonyms
Not Available
Poor quality drug data slowing you down?
Unlock 38% more drug discovery time and eliminate decision-making doubts with this one-stop guide to quality drug data.
Download eBook
Poor quality drug data slowing you down?
Download eBook

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
TargetActionsOrganism
UUncharacterized protein PA1000Not AvailablePseudomonas aeruginosa (strain ATCC 15692 / PAO1 / 1C / PRS 101 / LMG 12228)
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Categories

Drug Categories
Not Available
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as aryl phosphodiesters. These are aryl phosphates in which the phosphate is esterified at exactly two positions.
Kingdom
Organic compounds
Super Class
Organic acids and derivatives
Class
Organic phosphoric acids and derivatives
Sub Class
Phosphate esters
Direct Parent
Aryl phosphodiesters
Alternative Parents
Nitrobenzenes / Phenoxy compounds / Nitroaromatic compounds / Propargyl-type 1,3-dipolar organic compounds / Organic oxoazanium compounds / Organopnictogen compounds / Organooxygen compounds / Organonitrogen compounds / Organic oxides / Hydrocarbon derivatives
Substituents
Allyl-type 1,3-dipolar organic compound / Aromatic homomonocyclic compound / Aryl phosphodiester / Benzenoid / C-nitro compound / Hydrocarbon derivative / Monocyclic benzene moiety / Nitroaromatic compound / Nitrobenzene / Organic 1,3-dipolar compound
Molecular Framework
Aromatic homomonocyclic compounds
External Descriptors
aryl phosphate (CHEBI:3122)
Affected organisms
Not Available

Chemical Identifiers

UNII
1MF77LEI63
CAS number
Not Available
InChI Key
MHSVUSZEHNVFKW-UHFFFAOYSA-N
InChI
InChI=1S/C12H9N2O8P/c15-13(16)9-1-5-11(6-2-9)21-23(19,20)22-12-7-3-10(4-8-12)14(17)18/h1-8H,(H,19,20)
IUPAC Name
bis(4-nitrophenoxy)phosphinic acid
SMILES
OP(=O)(OC1=CC=C(C=C1)[N+]([O-])=O)OC1=CC=C(C=C1)[N+]([O-])=O

References

General References
Not Available
KEGG Compound
C03779
PubChem Compound
255
PubChem Substance
99443889
ChemSpider
250
BindingDB
50130915
ChEBI
3122
ChEMBL
CHEMBL1231178
ZINC
ZINC000001529745
PDBe Ligand
B4N
PDB Entries
3dh8

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility0.0116 mg/mLALOGPS
logP2.08ALOGPS
logP2.93Chemaxon
logS-4.5ALOGPS
pKa (Strongest Acidic)0.83Chemaxon
Physiological Charge-1Chemaxon
Hydrogen Acceptor Count6Chemaxon
Hydrogen Donor Count1Chemaxon
Polar Surface Area142.04 Å2Chemaxon
Rotatable Bond Count6Chemaxon
Refractivity75.81 m3·mol-1Chemaxon
Polarizability27.89 Å3Chemaxon
Number of Rings2Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterYesChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
PropertyValueProbability
Human Intestinal Absorption-0.5689
Blood Brain Barrier+0.8613
Caco-2 permeable-0.5325
P-glycoprotein substrateNon-substrate0.8112
P-glycoprotein inhibitor INon-inhibitor0.5249
P-glycoprotein inhibitor IINon-inhibitor0.8758
Renal organic cation transporterNon-inhibitor0.8859
CYP450 2C9 substrateNon-substrate0.7456
CYP450 2D6 substrateNon-substrate0.7797
CYP450 3A4 substrateSubstrate0.5371
CYP450 1A2 substrateNon-inhibitor0.6645
CYP450 2C9 inhibitorNon-inhibitor0.772
CYP450 2D6 inhibitorNon-inhibitor0.9258
CYP450 2C19 inhibitorNon-inhibitor0.7858
CYP450 3A4 inhibitorNon-inhibitor0.6684
CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.5738
Ames testAMES toxic0.926
CarcinogenicityCarcinogens 0.5555
BiodegradationNot ready biodegradable0.9659
Rat acute toxicity3.1728 LD50, mol/kg Not applicable
hERG inhibition (predictor I)Weak inhibitor0.5798
hERG inhibition (predictor II)Non-inhibitor0.7721
ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397)

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSsplash10-0006-6948000000-b1eb4254e6f068873bb6
LC-MS/MS Spectrum - LC-ESI-QQ , negativeLC-MS/MSsplash10-000i-0009000000-d5f9f89f73732a9439d2
LC-MS/MS Spectrum - LC-ESI-QQ , negativeLC-MS/MSsplash10-000i-0009000000-7961acf93ea4ca39ae8e
LC-MS/MS Spectrum - LC-ESI-QQ , negativeLC-MS/MSsplash10-000i-1908000000-b360365d152403c9df04
LC-MS/MS Spectrum - LC-ESI-QQ , negativeLC-MS/MSsplash10-000i-1900000000-55ea0d8e2b91ac0f9310
LC-MS/MS Spectrum - LC-ESI-QQ , negativeLC-MS/MSsplash10-000i-1900000000-11552e3273cc2d043659
Predicted 1H NMR Spectrum1D NMRNot Applicable
Predicted 13C NMR Spectrum1D NMRNot Applicable
Chromatographic Properties
Collision Cross Sections (CCS)
AdductCCS Value (Å2)Source typeSource
[M-H]-157.27104
predicted
DeepCCS 1.0 (2019)
[M+H]+159.62904
predicted
DeepCCS 1.0 (2019)
[M+Na]+165.72218
predicted
DeepCCS 1.0 (2019)

Targets

Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock new
insights and accelerate drug research.
Learn more
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
Learn more
Details1. Uncharacterized protein PA1000
Kind
Protein
Organism
Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 / 1C / PRS 101 / LMG 12228)
Pharmacological action
Unknown
General Function
Not Available
Specific Function
Not Available
Gene Name
Not Available
Uniprot ID
P20581
Uniprot Name
Uncharacterized protein PA1000
Molecular Weight
34305.9 Da
References
  1. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article]

Drug created at September 15, 2010 21:21 / Updated at June 12, 2020 16:52